Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to $1.6 million.

  • Trinity Biotech's Cash & Current Investments fell 7072.6% to $1.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.6 million, marking a year-over-year decrease of 7072.6%. This contributed to the annual value of $5.3 million for FY2024, which is 2106.28% down from last year.
  • According to the latest figures from Q2 2025, Trinity Biotech's Cash & Current Investments is $1.6 million, which was down 7072.6% from $5.3 million recorded in Q4 2024.
  • Over the past 5 years, Trinity Biotech's Cash & Current Investments peaked at $28.6 million during Q2 2021, and registered a low of $152000.0 during Q1 2023.
  • For the 5-year period, Trinity Biotech's Cash & Current Investments averaged around $13.9 million, with its median value being $7.4 million (2022).
  • As far as peak fluctuations go, Trinity Biotech's Cash & Current Investments soared by 8380.22% in 2021, and later plummeted by 9941.83% in 2023.
  • Over the past 5 years, Trinity Biotech's Cash & Current Investments (Quarter) stood at $25.9 million in 2021, then grew by 0.49% to $26.0 million in 2022, then tumbled by 74.05% to $6.8 million in 2023, then dropped by 21.06% to $5.3 million in 2024, then plummeted by 69.75% to $1.6 million in 2025.
  • Its Cash & Current Investments stands at $1.6 million for Q2 2025, versus $5.3 million for Q4 2024 and $190000.0 for Q3 2024.